Current recommendations for the anticoagulation of patients with atrial fibrillation

https://doi.org/10.1016/S0033-0620(96)80037-5Get rights and content

Abstract

Atrial fibrillation (AF) is the most commonly encountered cardiac rhythm disorder and is strongly associated with stroke. The risk of stroke and the benefit of anticoagulant therapy in patients with AF associated with mitral stenosis has been well accepted. Until recently the risk of stroke and the role of anticoagulant therapy in patients with nonrheumatic AF was unclear. Over the past decade studies have shown an approximate fivefold increase in the risk of stroke in patients with nonrheumatic AF. The results of large clinical trials have shown a benefit of treatment with anticoagulants and, to a lesser extent, aspirin for both the primary and secondary prevention of thromboembolic complications. Other than patients with a low risk of thromboembolic complications (primarily young patients without clinical risk factors), current guidelines recommend anticoagulation of most patients with AF. The studies that form the basis for these recommendations and the currently published guidelines are reviewed.

References (52)

  • TurpieAGG et al.

    Randomized comparison of two intensities of oral anticoagulant therapy after tissue heart valve replacement

    Lancet

    (1988)
  • Atrial Fibrillation: Current understandings and research imperatives

    J Am Coll Cardiol

    (1993)
  • WolfPA et al.

    Atrial fibrillation: A major contributor to stroke in the elderly: The Framingham Study

    Arch Intern Med

    (1987)
  • HalperinJL et al.

    Atrial fibrillation and stroke: New ideas, persisting dilemmas

    Stroke

    (1988)
  • CairnsJA et al.

    Nonrheumatic atrial fibrillation. Risk of stroke and role of antithrombotic therapy

    Circulation

    (1991)
  • HissRG et al.

    Electrocardiographic findings in 122,043 individuals

    Circulation

    (1962)
  • LakeFR et al.

    Atrial fibrillation and mortality in an elderly population

    Aust N Z J Med

    (1989)
  • KannelWB et al.

    Epidemiologic features of chronic atrial fibrillation

    N Engl J Med

    (1982)
  • OstranderLD et al.

    Electrocardiographic findings among the adult population of a total natural community, Tecumseh, Michigan

    Circulation

    (1965)
  • OnundarsonPT et al.

    Chronic atrial fibrillation—Epidemiologic features and 14 year follow-up: A case control study

    Eur Heart J

    (1987)
  • FeinbergWM et al.

    Prevalence, age distribution, and gender of patients with atrial fibrillation

    Arch Intern Med

    (1995)
  • CampbellA et al.

    Prevalence of abnormalities of electrocardiogram in old people

    Br Heart J

    (1974)
  • FurburgCD et al.

    Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study)

    Am J Cardiol

    (1994)
  • WolfPA et al.

    Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: The Framingham Study

    Neurology

    (1978)
  • TanakaH et al.

    Epidemiologic studies of stroke in Shibata, a Japanese provincial city: Preliminary report on risk factors for cerebral infarction

    Stroke

    (1985)
  • WolfPA et al.

    Atrial fibrillation as an independent risk factor for stroke: The Framingham Study

    Stroke

    (1991)
  • Cited by (14)

    • Management of patients with syncope and cardiac arrhythmias in an emergency department observation unit

      2001, Emergency Medicine Clinics of North America
      Citation Excerpt :

      Those with low risk (e.g., patients less than 65 years with no other risk factors) will have little benefit from warfarin (Coumadin). They might not derive much benefit from aspirin, but the risk and cost of treatment are low enough that it may be reasonable to treat it this way.65 Echocardiography is being used with increasing frequency to further risk-stratify patients.

    View all citing articles on Scopus
    View full text